To guarantee the best treatment, subjects with early-onset severe obesity should be sequenced in forehand of a bariatric surgery, and preferably treated with the new therapeutic Setmelanotide if a mutation in LEPR or POMC is detected. This evidence concerns the gene LEPR and obesity due to melanocortin 4 receptor deficiency.